Form 4: Progyny Director Sells Shares Under 10b5-1 Plan

Progyny Director Kevin K. Gordon reported the sale of 2,500 shares of common stock at $22.035 per share under a pre-arranged trading plan.

Summary

• Kevin K. Gordon, a Director of Progyny, Inc. (PGNY), sold 2,500 shares of common stock.
• The transaction occurred on August 11, 2025, at a price of $22.035 per share.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan, indicating it was a pre-scheduled transaction.
• Following the sale, Mr. Gordon beneficially owns a total of 20,527 shares of Progyny common stock.
• This total includes 12,501 shares held indirectly through the Kevin Gordon Revocable Declaration of Trust and 8,026 shares held directly.
• An earlier transfer of 5,147 shares from direct ownership to the Kevin Gordon Revocable Declaration of Trust occurred on June 2, 2025.

Sentiment

Score: 5

Explanation: The sale of 2,500 shares by a director is a minor transaction. The fact that it was conducted under a Rule 10b5-1 plan mitigates the negative signal typically associated with insider selling, as it indicates a pre-scheduled event rather than a discretionary sale based on new information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not necessarily a reaction to recent company performance or a sudden loss of confidence.

Negatives

• A director's sale of shares, even if pre-planned, reduces insider ownership and can still be perceived by some investors as a slightly negative signal.

Risks

• While the sale was pre-planned, significant insider selling, even under a 10b5-1 plan, can sometimes lead to negative market sentiment if not properly understood by investors.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Transfer of 5,147 shares to the Kevin Gordon Revocable Declaration of Trust on June 2, 2025, where the reporting person serves as trustee.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a minor data point, with the 10b5-1 plan mitigating concerns about a sudden loss of confidence.

Key Dates

Recommendation

The sale of 2,500 shares by a director, executed under a Rule 10b5-1 plan, is a routine insider transaction and does not provide a strong signal for a buy or sell recommendation. Investors should consider this as a minor data point and focus on the company's broader financial performance and strategic outlook.

Keywords

Progyny, PGNY, Insider Trading, Form 4, Stock Sale, Director, Kevin Gordon, Beneficial Ownership, 10b5-1 Plan